Further downstream of these issues, we observed a marked deficiency in SPR and PTPS levels in both CSF and tissue from PD patients compared to controls, while the expression of GCH1, a rate-limiting enzyme in the BH4 biosynthesis pathway, was similar to the control. This evidence concerns the gene SPR and Parkinson disease.